Clinical Trial Update: SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

View source ↗

Summary

A recruiting clinical trial in Hungary is studying the effects of oral semaglutide on blood sugar, weight, and cardiovascular risk in people with type 2 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rybelsus (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Type 2 Diabetes | Status: RECRUITING